A closed system for pathogen reduction of red blood cells for transfusion
Ended Project Grant Awarded Last action
- Award ID
- R44HL145783
- Recipient
-
Zata Pharmaceuticals, Inc. UEI LM1CSJF7LLS6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,468,550
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Funding
-
- $5,299,263.00 Federal
- $1,169,287.00 Non-federal
- Place of performance
- Worcester, MA 01605, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $1,169,287 | $0 | |
| Amendment | $1,169,287 | $0 | |
| Amendment | $1,169,287 | $1,169,287 | |
| Amendment | $0 | $0 | |
| Amendment | $1,010,910 | $0 | |
| Original award | $780,492 | $0 |
Quick answers
Who received award R44HL145783?
R44HL145783 was awarded to Zata Pharmaceuticals, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on March 1, 2019.
How much is award R44HL145783 worth?
$6,468,550 has been obligated on R44HL145783: $5,299,263 in federal funding and $1,169,287 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award